MedPath

Pilot Study for a Randomized Clinical Trial to Study Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects

Completed
Conditions
anti-obesity
Registration Number
NL-OMON34910
Lead Sponsor
PRA International EDS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
3
Inclusion Criteria

18-45 years,
BMI 27-35 kg/m2 (inclusive)

Exclusion Criteria

Suffering from: hepatitis B, cancer or HIV/Aids. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters blood in the 10 months preceding the start of the study.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To evaluate the logistics, feasibility, and safety of procedures for a clinical<br /><br>trial that will assess methodologies used to evaluate ketogenesis and<br /><br>glucose-dependent insulin secretion.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>N/A</p><br>
© Copyright 2025. All Rights Reserved by MedPath